SANUWAVE Health Inc. carries a market capitalization of 51.16M, placing it among publicly traded companies globally. Its enterprise value stands at 159.64M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 51.16M |
| Enterprise Value | 159.64M |
SANUWAVE Health Inc. currently has 8.59M shares outstanding.
| Shares Outstanding | 8.59M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
SANUWAVE Health Inc. trades at a trailing price-to-earnings ratio of 9.24. The price-to-sales ratio is 3.34, and the price-to-book ratio stands at -0.61.
| PE Ratio | 9.24 |
| PS Ratio | 3.34 |
| PB Ratio | -0.61 |
| P/TBV Ratio | -17.77 |
| P/FCF Ratio | 20.06 |
| P/OCF Ratio | 25.61 |
On an enterprise value basis, SANUWAVE Health Inc. trades at an EV/EBITDA multiple of 38.41 and an EV/FCF ratio of 12.60. The EV/Sales ratio of 3.60 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 56.31 provides insight into valuation relative to core operating earnings.
| EV / Sales | 3.60 |
| EV / EBITDA | 38.41 |
| EV / EBIT | 56.31 |
| EV / FCF | 12.60 |
SANUWAVE Health Inc. maintains a current ratio of 1.31, meaning it holds 1.3x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 1,205.88, indicating moderate leverage, while an interest coverage ratio of 0.84 demonstrates limited ability to service its debt obligations.
| Current Ratio | 1.31 |
| Quick Ratio | 0.92 |
| Debt / Equity | 1,205.88 |
| Debt / EBITDA | 5.33 |
| Interest Coverage | 0.84 |
| Return on Equity (ROE) | N/A |
| Return on Assets (ROA) | 47.24 |
| Return on Invested Capital (ROIC) | 16.07 |
| Return on Capital Employed (ROCE) | -9.28 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 1.82 |
SANUWAVE Health Inc.'s stock has declined approximately -83.81833% over the past 52 weeks. The 50-day moving average sits at 12.52, while the 200-day moving average is 22.92.
| Beta (5Y) | N/A |
| 52-Week Price Change | -83.81833% |
| 50-Day Moving Average | 12.52 |
| 200-Day Moving Average | 22.92 |
| Average Volume (20 Days) | N/A |
Over the trailing twelve months, SANUWAVE Health Inc. generated 44.33M in revenue and converted that into 16.05M in net income, yielding earnings per share of 1.79. EBITDA reached 4.16M, while operating income came in at 2.84M.
| Revenue | 44.33M |
| Gross Profit | 34.02M |
| Operating Income | 2.84M |
| Pretax Income | 16.14M |
| Net Income | 16.05M |
| EBITDA | 4.16M |
| EBIT | 2.84M |
| Earnings Per Share (EPS) | 1.79 |
SANUWAVE Health Inc. holds 10.78M in cash and equivalents against 22.16M in total debt, resulting in a net debt position of 9.79M. Total book value stands at -244.11M, with working capital of 5.65M providing operational flexibility.
| Cash & Cash Equivalents | 10.78M |
| Total Debt | 22.16M |
| Net Debt | 9.79M |
| Equity (Book Value) | -244.11M |
| Book Value Per Share | -28.47 |
| Working Capital | 5.65M |
SANUWAVE Health Inc. produced 5.79M in operating cash flow over the past twelve months. After subtracting -1.94M in capital expenditures, free cash flow totaled 3.85M - equivalent to 0.45 per share.
| Operating Cash Flow | 5.79M |
| Capital Expenditures | -1.94M |
| Free Cash Flow | 3.85M |
| FCF Per Share | 0.45 |
SANUWAVE Health Inc. operates with a gross margin of 76.74, reflecting its pricing power and cost economics. The operating margin of 6.40 and net profit margin of 36.21 provide insight into operational efficiency.
| Gross Margin | 76.74 |
| Operating Margin | 6.40 |
| Pretax Margin | 36.40 |
| Profit Margin | 36.21 |
| EBITDA Margin | 9.38 |
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | 4.69 |
| FCF Yield | 4.98 |
SANUWAVE Health Inc.'s most recent stock split took place on October 18, 2024 with a 375:1 split ratio.
| Last Split Date | 10/18/2024 |
| Split Ratio | 375:1 |
SANUWAVE Health Inc. posts an Altman Z-Score of -7.93, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | -7.93 |